Clindamycin Phosphate and Tretinoin (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the Clindamycin Phosphate and Tretinoin drug offered from Actavis Pharma, Inc.. This Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient],Retinoid [EPC],Retinoids [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
| NON-PROPRIETARY NAME: | Clindamycin Phosphate and Tretinoin |
| SUBSTANCE NAME: | CLINDAMYCIN PHOSPHATE; TRETINOIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient],Retinoid [EPC],Retinoids [Chemical/Ingredient] |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | GEL |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-07-05 |
| END MARKETING DATE: | 0000-00-00 |
Clindamycin Phosphate and Tretinoin HUMAN PRESCRIPTION DRUG Details:
| Item Description | Clindamycin Phosphate and Tretinoin from Actavis Pharma, Inc. |
| LABELER NAME: | Actavis Pharma, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 12; .25(mg/g; mg/g) |
| START MARKETING DATE: | 2016-07-05 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0472-1790_4ecd7ca6-80dd-445d-bcd9-e4f630cbec71 |
| PRODUCT NDC: | 0472-1790 |
| APPLICATION NUMBER: | ANDA202564 |
Other CLINDAMYCIN PHOSPHATE; TRETINOIN Pharmaceutical Manufacturers / Labelers:
